Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Wentworth

Showing results (81-90 of 143) with videos related to

Pageof 15
Sort By:
Obesity Surgery|November 22, 2017
Detailed Description of Change in Serum Cholesterol Profile with Incremental Weight Loss After Restrictive Bariatric SurgeryGeraldine J Ooi, Arul Earnest, Lisa Doyle, et al.
Diabetes Care|July 14, 2018
A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at RiskMaria J Redondo, Susan Geyer, Andrea K Steck, et al.
The Journal of Clinical Endocrinology and Metabolism|May 19, 2017
Can Non-HLA Single Nucleotide Polymorphisms Help Stratify Risk in TrialNet Relatives at Risk for Type 1 Diabetes?Andrea K Steck, Ping Xu, Susan Geyer, et al.
Molecular Therapy. Nucleic Acids|October 29, 2014
Antisense Oligonucleotide-mediated Suppression of Muscle Glycogen Synthase 1 Synthesis as an Approach for Substrate Reduction Therapy of Pompe DiseaseNicholas P Clayton, Carol A Nelson, Timothy Weeden, et al.
Diabetes Research and Clinical Practice|October 31, 2025
Islet autoimmunity in young First Nations women with prediabetes and type 2 diabetesMary M Wicks, Anna J Wood, Angela Titmuss, et al.
Cell Death and Differentiation|December 16, 2017
CD52 inhibits Toll-like receptor activation of NF-κB and triggers apoptosis to suppress inflammationMaryam Rashidi, Esther Bandala-Sanchez, Kate E Lawlor, et al.
Obesity Surgery|May 26, 2016
Modified thresholds for fibrosis risk scores in nonalcoholic fatty liver disease are necessary in the obeseGeraldine J Ooi, Paul R Burton, Lisa Doyle, et al.
Nucleic Acid Therapeutics|January 12, 2013
Systemic delivery of a Peptide-linked morpholino oligonucleotide neutralizes mutant RNA toxicity in a mouse model of myotonic dystrophyAndrew J Leger, Leocadia M Mosquea, Nicholas P Clayton, et al.
The Journal of Biological Chemistry|February 22, 2000
A dominant-negative peroxisome proliferator-activated receptor gamma (PPARgamma) mutant is a constitutive repressor and inhibits PPARgamma-mediated adipogenesisM Gurnell, J M Wentworth, M Agostini, et al.
Obesity Surgery|December 15, 2016
Effects of Bariatric Surgery on Liver Function Tests in Patients with Nonalcoholic Fatty Liver DiseaseGeraldine J Ooi, Paul R Burton, Lisa Doyle, et al.
Pageof 15

Showing results (81-90 of 143) with videos related to

Sort By:
Pageof 15
Obesity Surgery|November 22, 2017
Detailed Description of Change in Serum Cholesterol Profile with Incremental Weight Loss After Restrictive Bariatric SurgeryGeraldine J Ooi, Arul Earnest, Lisa Doyle, et al.
Diabetes Care|July 14, 2018
A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at RiskMaria J Redondo, Susan Geyer, Andrea K Steck, et al.
The Journal of Clinical Endocrinology and Metabolism|May 19, 2017
Can Non-HLA Single Nucleotide Polymorphisms Help Stratify Risk in TrialNet Relatives at Risk for Type 1 Diabetes?Andrea K Steck, Ping Xu, Susan Geyer, et al.
Molecular Therapy. Nucleic Acids|October 29, 2014
Antisense Oligonucleotide-mediated Suppression of Muscle Glycogen Synthase 1 Synthesis as an Approach for Substrate Reduction Therapy of Pompe DiseaseNicholas P Clayton, Carol A Nelson, Timothy Weeden, et al.
Diabetes Research and Clinical Practice|October 31, 2025
Islet autoimmunity in young First Nations women with prediabetes and type 2 diabetesMary M Wicks, Anna J Wood, Angela Titmuss, et al.
Cell Death and Differentiation|December 16, 2017
CD52 inhibits Toll-like receptor activation of NF-κB and triggers apoptosis to suppress inflammationMaryam Rashidi, Esther Bandala-Sanchez, Kate E Lawlor, et al.
Obesity Surgery|May 26, 2016
Modified thresholds for fibrosis risk scores in nonalcoholic fatty liver disease are necessary in the obeseGeraldine J Ooi, Paul R Burton, Lisa Doyle, et al.
Nucleic Acid Therapeutics|January 12, 2013
Systemic delivery of a Peptide-linked morpholino oligonucleotide neutralizes mutant RNA toxicity in a mouse model of myotonic dystrophyAndrew J Leger, Leocadia M Mosquea, Nicholas P Clayton, et al.
The Journal of Biological Chemistry|February 22, 2000
A dominant-negative peroxisome proliferator-activated receptor gamma (PPARgamma) mutant is a constitutive repressor and inhibits PPARgamma-mediated adipogenesisM Gurnell, J M Wentworth, M Agostini, et al.
Obesity Surgery|December 15, 2016
Effects of Bariatric Surgery on Liver Function Tests in Patients with Nonalcoholic Fatty Liver DiseaseGeraldine J Ooi, Paul R Burton, Lisa Doyle, et al.
Pageof 15